Pfizer's stop-smoking drug Chantix will go on sale in Australia this month, but with warnings of links to depression and suicidal thoughts. The FDA is currently reviewing reports of the drug's potential to cause psychiatric side effects. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.
